|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.965 USD | -4.46% |
|
+2.44% | -16.98% |
| Apr. 15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
June 14 (Reuters) - Novavax Inc said on Monday its COVID-19 vaccine candidate showed 90.4% overall efficacy against the disease in a late-stage trial. (Reporting by Mrinalika Roy in Bengaluru; Editing by Anil D'Silva)
| 1st Jan change | Capi. | |
|---|---|---|
| -16.98% | 581M | |
| +0.76% | 43.84B | |
| +4.47% | 41.68B | |
| +45.49% | 41.25B | |
| -10.92% | 27.04B | |
| +7.47% | 25.53B | |
| -25.63% | 18.18B | |
| -4.16% | 12.29B | |
| +25.51% | 12.29B | |
| +6.89% | 11.15B |
NOVAVAX, INC. 
